Aurubis (NDA) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 May, 2026Executive summary
Operating EBT for the first nine months was €286 million, down from €333 million year-over-year, while operating EBITDA remained nearly flat at €462 million versus €475 million, supported by higher metal prices and strong copper product revenues despite major maintenance shutdowns.
Net cash flow improved sharply to €357 million from €52 million last year, driven by robust earnings, lower inventories, and higher receivables.
Largest scheduled maintenance shutdown at the Bulgarian site was completed on time and within budget, supporting operational stability and efficiency.
Strategic investments and project ramp-ups, especially in the U.S. (Richmond), progressed with over 70% of €1.7 billion CapEx already spent, targeting €260 million in future annual EBITDA.
ROCE declined to 9.1% from 11.1% due to higher capital employed for growth projects not yet contributing to earnings.
Financial highlights
Revenues rose 7% year-over-year to €13,781 million, driven by higher copper and precious metal prices.
Gross profit was €1,232 million, down 4% year-over-year; gross margin exceeded €1.5 billion.
Operating EBITDA for the first nine months was €462 million, nearly flat year-over-year; EBIT dropped 11% to €293 million.
Free cash flow improved versus prior year, though Q3 free cash flow was -€276 million due to high CapEx and dividend payout.
Equity ratio at 56.1%, debt coverage at 0.6, both well within target ranges.
Outlook and guidance
Full-year operating EBT guidance narrowed to €330–370 million, with expectations to land near the midpoint.
Net cash flow forecast for the year is €500–600 million.
Operating ROCE expected between 8% and 10% for the group, with segment-specific guidance: Multimetal Recycling EBT €50–70 million (ROCE 4–6%), Custom Smelting & Products EBT €340–370 million (ROCE 16–18%).
Stable demand anticipated for copper cathodes and wire rod; high sulfuric acid revenues expected.
No major plant standstills expected next year, supporting improved throughput.
Latest events from Aurubis
- EBT up 19% to €413m, strong cash flow, major investments, and stable outlook amid robust copper demand.NDA
Q4 20248 Jul 2026 - US expansion and multimetal focus drive growth, targeting 15% ROCE by 2028/29.NDA
CMD 20258 Jul 2026 - Operating EBT up 30% year-over-year; full-year guidance confirmed at upper end.NDA
Q3 23/248 Jul 2026 - Strong H1 results, revenue growth, and cash flow support guidance amid high investment costs.NDA
Q2 20258 Jul 2026 - Full-year EBT guidance raised to €425–525 million on strong H1 results and project progress.NDA
Q2 202615 May 2026 - Revenues up 25% and EBT forecast raised on strong metal prices and robust copper demand.NDA
Q1 202613 Apr 2026 - Q1 operating EBT up 17.5% to €130M, revenues up 8%, and net cash flow at €178M.NDA
Q1 202519 Dec 2025 - Strong cash flow, higher dividend, and strategic progress despite lower earnings.NDA
Q4 20256 Dec 2025